This article was originally published in The Gray Sheet
Executive SummaryFormer Guidant Japanese vascular intervention division director Gary King is named VP-worldwide marketing on Aug. 19. King is credited with establishing a sales organization in Japan and increasing revenues by more than $80 mil. while at Guidant. Most recently, he served as Advanced Respiratory, Inc.'s national sales director...
You may also be interested in...
AstraZeneca/Daiichi Sankyo and Seattle Genetics presented exciting data at SABCS on drugs that extended survival in patients who had exhausted most treatment options.
US FDA officials tell industry that implementing a quality metrics program is an agency priority and that a rejiggered program will incorporate various elements of other quality metrics initiatives being piloted by the agency, industry and academia.
Sanofi eyes $1bn top line growth from OTC switches of ED drug Cialis and flu drug Tamiflu after they launch by 2026, says CEO Paul Hudson. Like switch consultants, though, he acknowledges the high bar for approval moving additional Rx ingredients to OTC.